Related to Horizon Licenses X-Man Panel for Viral Diseases and Leukemias from the University of Minnesota

• GSK and Concert Forge $1B Alliance for Deuterium-Modified Drugs
  
• Scientists Reveal E. coli’s Survival Technique
  
• Novartis Vaccines Institute Gets Roughly $7M to Develop Bivalent Typhoid Vaccine
  
• Scientists Pinpoint Enzyme Involved in Resistance to Childhood Leukemia Drug
  
• Northeast Biodefense Center Pockets $46M from the NIAID
  
• NIDA Gives Albert Einstein College $3M to Study HIV-Related Brain Disease
  
• Quest Diagnostics Launches HIV Test to Determine Patients Suitable for Entry Inhibitors
  
• Spectrum Garners $9.5M in New Financing Round
  
• Spectrum Garners $10M in New Financing Round
  
• UK HIV Vaccine Consortium Orders Candidate Genes from Geneart
  
• LabCorp to Pick Up Monogram Biosciences for Roughly $106.7M
  
• Morphotek Taps Synageva in Cancer and Infectious Disease Deal
  
• FDA Asks Spectrum Pharmaceuticals for Past Clinical Study Data to Help Expand Approval of NHL Drug
  
• Gilead and Tibotec Ink Pact to Develop Once-Daily HIV Therapy
  
• Researchers Begin to Unlock Secret to Retroviral Transmission
  
• ImmunoVaccine Technologies Collaborates with Scancell to Advance DNA Vaccine Delivery
  
• Researchers Find Gene Silenced Early in the Development of Chronic Lymphocytic Leukemia
  
• Horizon Gains Patents to Cell Lines that Model Genetic Mutations Seen in Cancer
  
• Forest Licenses Antibiotic to AstraZeneca in Europe and Other Markets
  
• FDA Raps J&J's Knuckles over Clinical Trials of Ceftobiprole Antibiotic